|
Neoplasia
Citations 1-10 of 3993 total displayed.
|
Most recent content
(15 May 2008):
|
Myelodysplastic syndromes
- Stephen D. Nimer
Blood 2008; 111: 4841-4851.
[Abstract]
[Full text]
[PDF]
Appraisal of immunoglobulin free light chain as a marker of response
- Angela Dispenzieri, Lijun Zhang, Jerry A. Katzmann, Melissa Snyder, Emily Blood, Roberta DeGoey, Kimberly Henderson, Robert A. Kyle, Martin M. Oken, Arthur R. Bradwell, and Philip R. Greipp
Blood 2008; 111: 4908-4915.
[Abstract]
[Full text]
[PDF]
Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century
- Hermann Brenner, Adam Gondos, and Dianne Pulte
Blood 2008; 111: 4916-4921.
[Abstract]
[Full text]
[PDF]
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
- Jean-Jacques Kiladjian, Francisco Cervantes, Franck W. G. Leebeek, Christophe Marzac, Bruno Cassinat, Sylvie Chevret, Dominique Cazals-Hatem, Aurélie Plessier, Juan-Carlos Garcia-Pagan, Sarwa Darwish Murad, Sebastian Raffa, Harry L. A. Janssen, Claude Gardin, Sophie Cereja, Carole Tonetti, Stéphane Giraudier, Bertrand Condat, Nicole Casadevall, Pierre Fenaux, and Dominique C. Valla
Blood 2008; 111: 4922-4929.
[Abstract]
[Full text]
[PDF]
Structural and numerical variation of FLT3/ITD in pediatric AML
- Soheil Meshinchi, Derek L. Stirewalt, Todd A. Alonzo, Titus J. Boggon, Robert B. Gerbing, Jennifer L. Rocnik, Beverly J. Lange, D. Gary Gilliland, and Jerald P. Radich
Blood 2008; 111: 4930-4933.
[Abstract]
[Full text]
[PDF]
Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3
- Yung-Chi Chang, Tse-Ching Chen, Chun-Ting Lee, Chih-Ya Yang, Hsei-Wei Wang, Chao-Ching Wang, and Shie-Liang Hsieh
Blood 2008; 111: 5054-5063.
[Abstract]
[Full text]
[PDF]
Targeting NF- B in Waldenstrom macroglobulinemia
- Xavier Leleu, Jérôme Eeckhoute, Xiaoying Jia, Aldo M. Roccaro, Anne-Sophie Moreau, Mena Farag, Antonio Sacco, Hai T. Ngo, Judith Runnels, Molly R. Melhem, Nicolas Burwick, Abdelkareem Azab, Feda Azab, Zachary Hunter, Evdoxia Hatjiharissi, Daniel R. Carrasco, Steven P. Treon, Thomas E. Witzig, Teru Hideshima, Myles Brown, Kenneth C. Anderson, and Irene M. Ghobrial
Blood 2008; 111: 5068-5077.
[Abstract]
[Full text]
[PDF]
MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
- Mojca Jongen-Lavrencic, Su Ming Sun, Menno K. Dijkstra, Peter J. M. Valk, and Bob Löwenberg
Blood 2008; 111: 5078-5085.
[Abstract]
[Full text]
[PDF]
Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo
- Chie Nishioka, Takayuki Ikezoe, Jing Yang, Atsushi Miwa, Taizo Tasaka, Yoshio Kuwayama, Kazuto Togitani, H. Phillip Koeffler, and Akihito Yokoyama
Blood 2008; 111: 5086-5092.
[Abstract]
[Full text]
[PDF]
The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph– acute lymphoblastic leukemia cells
- Anna Scuto, Mark Kirschbaum, Claudia Kowolik, Leo Kretzner, Agnes Juhasz, Peter Atadja, Vinod Pullarkat, Ravi Bhatia, Stephen Forman, Yun Yen, and Richard Jove
Blood 2008; 111: 5093-5100.
[Abstract]
[Full text]
[PDF]
|
|
